The Maintenance Treatment of "ITIVA" in AML Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Maintenance Treatment of "ITIVA" in AML Patients — Stella

Home/Acute Myeloid Leukemia/

View on ClinicalTrials.gov

Recruiting

Back to Acute Myeloid Leukemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan

Key details

Sponsor

Henan Cancer Hospital

Enrollment target

~130 participants

Started

July 2023

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

14 Years and older

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.